Operating profit before deduction of amortization: enlivex.com (ENLV)
The prospects of Enlivex Therapeutics (ENLV) depend on the outcomes of immunotherapy trials, while the current liquidity reserve remains stable. The company plans to generate revenue by bringing the drug Allocetra to market to combat sepsis. The absolute cash result of operations allows for daily monitoring of the financial condition, and its current level is 0.00. Simultaneously, Enlivex Therapeutics is implementing energy-saving systems and emission filtration in its laboratories.
Enlivex Therapeutics Ltd. (ENLV) - metric breakdowns and financial figures
- stock value and consensus price forecast:
- company stock exchange capitalization indicators:
- shareholders' equity book value data:
- debt level and financial liquidity data:
Debt to Equity Ratio Enlivex Therapeutics|ENLV - Long-Term Debt to Capital|Current Liabilities to Capital Enlivex Therapeutics, Ltd.|ENLV - Company Aggregate Debts|Debts to Book Value Enlivex Therapeutics Ltd|ENLV - Company Long-Term Debt|Company Short-Term Indebtedness Enlivex Therapeutics|Quick Liquidity enlivex.com
- earnings and multiples data:
ENLV - Net Profit|Company Profit Forecast Enlivex Therapeutics|ENLV - Price to Earnings Ratio|Future Price to Earnings Enlivex Therapeutics, Ltd.|ENLV - PEG Multiple|Company Value to EBITDA Enlivex Therapeutics, Ltd.|ENLV - Operating profit before deduction of amortization|Earnings per share for the last 12 months Enlivex Therapeutics|ENLV - Net earnings per share for the last 12 months|Year-over-year earnings per one share growth for the last 12 months enlivex.com|ENLV - Net earnings per share growth this year|Projected earnings per share increase next year Enlivex Therapeutics
- sales and revenue indicators:
Summary company analytics:Enlivex Therapeutics
EBITDA cash flow reflects the daily cash balance after deducting operating expenses, allowing for an assessment of the management efficiency of external GMP contracts and laboratories at Enlivex Therapeutics (ENLV). This indicator measures the difference between demand-driven revenue and outsourcing costs, where a stable trend confirms the predictability of the business model, while volatility signals risks associated with third-party vendor dependency and asset quality.
Competitors of Enlivex Therapeutics (ENLV)
Operating income before deduction of amortization argenx.com (ARGX)|BNTX - Profit before payment of interest, taxes and amortization|Abivax Corp (ABVX) - Operating profit before deduction of amortization|ADMA Corp (ADMA) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization Protagonist Therapeutics|Operating profit before deduction of amortization IMVT|Operating profit EBITDA kiniksa.com|Profit before payment of interest, taxes and amortization Grifols Group (GRFS)|Adaptive Biotechnologies Corporation - Operating profit before amortization|Operating profit EBITDA CLDX (celldex.com)|Aurinia Pharma (AUPH) - Profit before interest, taxes and amortization|BioCryst - Operating profit EBITDA|VERA: Profit before payment of interest, taxes and amortization|DNTH: Operating profit EBITDA|Pharvaris - Income before deduction of interest, taxes and amortization|ABCL (AbCellera Bio) - Operating profit EBITDA|Operating profit EBITDA Tourmaline|Operating profit EBITDA PGEN|PHAR (pharming.com) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA NKTR (nektar.com)|Upstream Bio (UPB) - Profit before interest, taxes and amortization|ZBIO: Operating profit before deduction of amortization|Profit before interest, taxes and amortization Immunome Bio|GOSS: Operating profit EBITDA|KALV: Company profit before taxes, interest and amortization|SEPN (septerna.com) - Operating profit EBITDA|Pieris Pharmaceuticals, Inc. - Profit before deduction of interest, taxes, depreciation and amortization|Profit before payment of interest, taxes and amortization Savara Inc. (SVRA)|Operating profit EBITDA Rigel Corp (RIGL)|Profit before payment of interest, taxes and amortization AnaptysBio Inc ANAB|astriatx.com (ATXS) - Profit before interest, taxes and amortization|enGene Bio - Operating profit EBITDA|Profit before deduction of interest, taxes, depreciation and amortization RAPT|JBIO: Operating profit EBITDA|Aclaris - Income before deduction of interest, taxes and amortization|KYTX (Kyverna Therapeutics, Inc) - Operating profit EBITDA|TLSA: Income before deduction of interest, taxes and amortization|Operating profit before deduction of amortization CABA (Cabaletta Bio)|VTYX - Profit before interest, taxes and amortization|Operating profit EBITDA THTX (Theratechnologies, Inc)|Company profit before taxes, interest and amortization AVTX (Avalo Therapeutics Inc.)|ELDN: Operating profit before deduction of amortization|AGEN - Operating profit EBITDA|Climb Bio Inc. (CLYM) - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization ZURA (Zura Bio)|Operating profit before deduction of amortization ATYR|ADAG: Income before deduction of interest, taxes and amortization|Operating profit EBITDA IMA|Operating income before deduction of amortization Shattuck Therapeutics|Operating profit EBITDA EQ (Equillium Inc)|Company profit before taxes, interest and amortization CNTB (Connect Pharma)|IMUX - Profit before payment of interest, taxes and amortization|Operating income before deduction of amortization atarabio.com ATRA|IFRX: Operating profit EBITDA|XFOR (X4 Pharmaceuticals, Inc) - Profit before payment of interest, taxes and amortization|Profit before payment of interest, taxes and amortization adicetbio.com|CELU: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization INmune Bio Corporation (INMB)|Operating profit before deduction of amortization Barinthus Biotherapeutics Corp BRNS|Profit before payment of interest, taxes and amortization Kezar Life Sciences KZR|Income before deduction of interest, taxes and amortization SABS|AKTX - Profit before payment of interest, taxes and amortization|QTTB - Operating profit EBITDA|GOVX (GeoVax Labs Inc) - Operating profit before deduction of amortization|Operating profit before deduction of amortization Edesa|IBIO (iBio, Inc.) - Operating profit EBITDA|CARM: Income before deduction of interest, taxes and amortization|Operating profit EBITDA XTLB|Operating profit before deduction of amortization Bolt Biotherapeutics, Inc. BOLT|Operating profit EBITDA HCWB (hcwbiologics.com)|Income before deduction of interest, taxes and amortization APVO|AIM ImmunoTech, Inc. - Operating profit EBITDA|ADTX (Aditxt Inc.) - Operating profit before amortization|GRI: Operating profit EBITDA|Operating profit before deduction of amortization XORTX Therapeutics|Operating profit before deduction of amortization HIND|REVB: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization indaptusrx.com (INDP)|Operating profit before deduction of amortization Scinai Immunotherapeutics SCNI|Operating profit EBITDA CALI (CalciMedica Inc)|AFMD: Operating profit before amortization|ALLK - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization hookipapharma.com|IGMS: Operating profit EBITDA|ITOS: Company profit before taxes, interest and amortization|OCEA (Ocean Biomedical Corp) - Operating profit EBITDA|TCBP: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Third Harmonic Bio, Inc (THRD)
